The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Open accessAbstract
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, as well as developments in diagnostic procedures and improvements in therapy and prevention. These therapies make it possible to eliminate hepatitis C as a major public health threat, as per the World Health Organization target, although the timeline and feasibility vary from region to region. These European Association for the Study of the Liver recommendations on treatment of hepatitis C describe the optimal management of patients with recently acquired and chronic HCV infections in 2020 and onwards.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–205 of 205
Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples
Lamoury, F. M. J., Hajarizadeh, B., Soker, A., Martinez, D., Quek, C. Y. J., Cunningham, P., Catlett, B., Cloherty, G., Marks, P. S., Amin, J., et al. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.05.010 · Cited by 20
Hernández‐Conde, M., Fernández, I., Perelló, C., Gallego, A., Bonacci, M., Pascasio, J. M., Romero‐Gómez, M., Llerena, S., Fernández‐Rodríguez, C., Urda, J. L. C., et al. (2018) · Journal of Viral Hepatitis · doi:10.1111/jvh.13008 · Cited by 19
Pol, S., Pockros, P. J., Pugatch, D. L., Bräu, N., Landis, C. S., Elkhashab, M., Sasadeusz, J. J., Tran, A., Hu, Y., Kosloski, M. P., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31967-0 · Cited by 17
Dufour, J., Zuckerman, E., Zadeikis, N., Hézode, C., Paik, S. W., Andreoné, P., Weiland, O., Slim, J., Flamm, S. L., Morgan, T., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31432-0 · Cited by 12
Mangia, A., Milligan, S. C., Khalili, M., FAGIUOLI, S., Shafran, S. D., Carrat, F., Ouzan, D., Papatheodoridis, G., Ramji, A. S., Borgia, S. M., et al. (2019) · Journal of Hepatology · doi:10.1016/s0618-8278(19)30003-9 · Cited by 12
Self-citation
Cited by
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Sangro, B., Argemi, J., Ronot, M., Paradis, V., Meyer, T., Mazzaferro, V., Jepsen, P., Golfieri, R., Galle, P., Dawson, L., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.028 · Cited by 985
Global epidemiology of cirrhosis — aetiology, trends and predictions
Huang, D. Q., Terrault, N. A., Tacke, F., Gluud, L. L., Arrese, M., Bugianesi, E., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00759-2 · Cited by 839
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Cornberg, M., Sandmann, L., Jaroszewicz, J., Kennedy, P., Lampertico, P., Lemoine, M., Lens, S., Testoni, B., Lai-Hung Wong, G., & Russo, F. P. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.03.018 · Cited by 437
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Metadata
- Authors
- Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 73
- Issue
- 5
- Pages
- 1170-1218
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3088020815
- Cited by
- 1,252
- References
- 205
- FWCI
- 88.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.